{"id":2763,"date":"2013-10-08T10:13:25","date_gmt":"2013-10-08T10:13:25","guid":{"rendered":"\/?p=2763"},"modified":"2013-10-08T10:13:43","modified_gmt":"2013-10-08T10:13:43","slug":"titan-pharmaceuticals-inc-otcbbttnp-fills-gap-even-faster","status":"publish","type":"post","link":"\/articles\/titan-pharmaceuticals-inc-otcbbttnp-fills-gap-even-faster\/","title":{"rendered":"Titan Pharmaceuticals, Inc. (OTCBB:TTNP) Fills Gap Even Faster"},"content":{"rendered":"

Titan Pharmaceuticals, Inc. (OTCBB:TTNP<\/a>) really took off on Monday, vaulting over the $1 levels to reach $1.16 on the day, on buyin\"TTNP0810.png\"g volumes of $3.6 million. The ticker added nearly 24% on the day, which was reserved for the beginning of a new review procedure from the FDA. The result of the procedure is unknown, but TTNP<\/a> seems equipped with optimism, at least until the meetings happen in November, and maybe even after that, in case of a positive outcome. <\/p>\n

While TTNP<\/a> is not seeing another promotion like the one that boosted it in May, the ticker is becoming active after a summer in the doldrums, awaiting the development with the Probruphine anti-opioid treatment. \"SNGX0810.png\"<\/p>\n

Message boards are wildly optimistic about this ticker, just as a few days ago there were warnings of a quick reversal. Spikes in pharmaceutical stocks are often a matter of hype and loyalty, and TTNP<\/a> has a good past record, both in terms of real pharmaceutical business and in a responsive, actively traded stock.<\/p>\n

The solid process of a new drug is a great booster for a pharmaceutical company. The rise in TTNP<\/a> in a way resembles that of NanoViricides, Inc. (AMEX:NNVC<\/a>), which fulfilled its promise to list to a higher tier, while continuing its drive to bring its dengue fever treatment to market. The larger exposure was certainly a factor, and NNVC<\/a> doubled in price in three months, keeping above $5.20, and even touching $7 for a short period.<\/p>\n

Another ticker that received excellent news, a large R&D grant, managed to double in price, from $1 to $2: Soligenix, Inc. (OTCBB:SNGX<\/a>), though in the last few days it retreated from a peak around $2.40 and toward $2.\"NNVC0810.png\"<\/p>\n

TTNP<\/a> has the potential to attract longer-term investors, even beyond the November events. The eventual marketing of the anti-addiction treatment could offer support to the shares in the longer term. But between those events, the company may very well suffer a setback deep enough to wipe out a large part of investments.<\/p>\n

The next few weeks will probably be promising buying time for TTNP<\/a>, but do your own research of the company’s potential before you take up positions, and do not invest sums that you could not afford to lose.<\/p>\n","protected":false},"excerpt":{"rendered":"

Titan Pharmaceuticals, Inc. (OTCBB:TTNP) really took off on Monday, vaulting over the $1 levels to reach $1.16 on the day, on buying volumes of $3.6 million. The ticker added nearly 24% on the day,...<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[695,875,11],"class_list":["post-2763","post","type-post","status-publish","format-standard","hentry","category-news","tag-nnvc","tag-sngx","tag-ttnp"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/2763","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=2763"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/2763\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=2763"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=2763"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=2763"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}